The economy may finally have a clear runway for takeoff in 2014.» Read More
Today's six stocks worth watching.
Markets opened lower on Wednesday after a report showed retail sales fell for a second straight month and report out of Europe that several banks will fail their stress tests. Madelynn Matlock, director of international investments at Huntington Funds and John Browne, senior market strategist at Euro Pacific Capital discussed their insights.
Participants in that auction tell me, in recent days, it has slowed and while there was significant interest from PE initially, that interest is now being described as more modest, though bankers tell me a few sponsors continue to work on a deal.
BlackRock is out with its third quarter allocation report, and Robert Doll, BlackRock vice chairman, along with Curtis Arledge, BlackRock cio of fixed income, fundamental portfolios, gave their outlook on the economy and the markets.
Intel's conference call was about as optimistic and bullish as any I've heard.
Add Clorox to the "One Decision" stock member club because this company is so strong that the thought of selling won't enter your mind.
U.S. stock index futures were higher ahead of the open Wednesday, thanks in part to better-than-expected earnings from Intel, suggesting the major averages could extend their winning streak to a seventh consecutive session.
Odds of a double dip continue to drop. We now have three companies in three different fields that have not tried to dampen expectations for the second half of the year: Intel in tech, CSX in transports, and Alcoa in aluminum.
Here's what analysts are saying about retail sales for back-to-school.
Flextronics has been flexing its muscle with a big rally this month, and now our screens are lighting up with bullish activity.
David Bloom is the global head of foreign exchange strategy at HSBC and earlier this year found himself going against the trend when the euro went into freefall. With other houses predicting parity for euro-dollar, Bloom refused to follow.
Money from central banks has acted like a botox shot for the world economy, covering up unresolved problems, Satyajit Das, the author of 'Traders, Guns & Money: Knowns and Unknowns in the Dazzling World of Derivatives', told CNBC Wednesday.
David Novak, Chairman and CEO of Yum! Brands, spoke with Maria Bartiromo today on the Closing Bell in a first on CNBC interview right after the company released its results. For the second quarter, the company reported EPS of 58-cents, 3-cents better than analyst estimates. Revenue also beat estimates at $2.57 billion for the quarter, versus expectations of $2.54 billion.
CSX was not a fluke: after the close Dow Transports component Expeditors International said Q2 earnings will fall within $0.38-$0.40, above consensus of $0.30. EXPD is a freight forwarder: they buy air and cargo space on big volume and then resell it to customers.
Stocks closed higher Tuesday, the sixth straight session of gains, as investors focused on earnings and shrugged off a downgrade on Portugal. .
Big pharmaceutical companies have been beaten down by worries over patent expirations, a lack of new products and low price-to-earnings ratios. But health care strategists aren't all pessimistic.
What double dip? Two important blows against the "double dip" school today: GE CEO Jeff Immelt, in an interview on our air, said: "When you look at all the early indicators that we look at, like media buy, rail loading, passenger miles—all key early indicators—are trending better.
With over 120 deals backlogged, Fox said, "some 25 billion of product" could come into the market over the next 6-9 months, which is very positive.
Ford shares have been on a tear, nearly doubling in the past year. The automaker has finally turned a profit, delivering four consecutive quarters of income growth, the longest streak since 2005.
Wall Street needs a new crop of hearty growth stocks, something big and juicy like a new Google or maybe a crisp young Apple. Here are five private tech companies that investors would love to sink their teeth into.